Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Sell
5
XNCR Quote, Financials, Valuation and Earnings
Last price:
$23.92
Seasonality move
:
-1.15%
Day range:
$22.79 - $23.95
52-week range:
$15.31 - $27.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.71x
P/B ratio:
2.22x
Volume:
404.6K
Avg. volume:
760.9K
1-year change:
8.24%
Market cap:
$1.6B
Revenue:
$168.3M
EPS (TTM):
-$3.20
Analysts' Opinion
-
Consensus RatingXencor has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $32.50, Xencor has an estimated upside of 43.21% from its current price of $22.98.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $22.00 representing 100% downside risk from its current price of $22.98.
Fair Value
-
According to the consensus of 7 analysts, Xencor has 43.21% upside to fair value with a price target of $32.50 per share.
XNCR vs. S&P 500
-
Over the past 5 trading days, Xencor has underperformed the S&P 500 by -3.99% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Xencor does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Xencor revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Xencor reported revenues of $10.7M.
Earnings Growth
-
Xencor has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Xencor reported earnings per share of -$0.71.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
16.71x
EV / EBIT:
--
EV / Revenue:
12.68x
PEG ratio (5yr expected):
-0.12x
EV / Free cash flow:
41.45x
Price / Operating cash flow:
54.62x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-22.4%
Net Income Margin (TTM):
-232.77%
Return On Equity:
-30.65%
Return On Invested Capital:
-29.92%
Operating Margin:
-581.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $297M | $145.3M | $85.2M | $59.2M | $10.7M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $51.8M | -$147.6M | -$216.1M | -$18.3M | -$62.3M | |
| EBITDA | $60.5M | -$139.1M | -$189.1M | -$21.1M | -$42.4M | |
| Diluted EPS | $0.48 | -$1.99 | -$3.20 | -$0.40 | -$0.71 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $570.9M | $329.6M | $668M | $571.2M | $573.3M | |
| Total Assets | $646.3M | $697.3M | $835.3M | $778.4M | $983.6M | |
| Current Liabilities | $70.5M | $44.3M | $90M | $53M | $92M | |
| Total Liabilities | $77.9M | $78.4M | $112.6M | $109.4M | $262.7M | |
| Total Equity | $568.5M | $618.9M | $722.7M | $669M | $720.9M | |
| Total Debt | -- | -- | -- | -- | $17.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $110.7M | -$120.5M | $34.6M | -$27.3M | -$26M | |
| Cash From Investing | -$136.4M | $116.6M | -$268.3M | $45.3M | -$163.5M | |
| Cash From Financing | $37.2M | $4.4M | $210M | $356K | $187.7M | |
| Free Cash Flow | $71.5M | -$151M | $26.1M | -$30.7M | -$28.1M | |
XNCR
Sector
Market Cap
$1.6B
$47.7M
Price % of 52-Week High
84.36%
46.05%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
8.24%
-33.33%
Beta (5-Year)
0.722
0.760
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$24.10
200-day SMA
Buy
Level
$21.14
Bollinger Bands (100)
Buy
Level
18.25 - 24.31
Chaikin Money Flow
Buy
Level
16.2M
20-day SMA
Sell
Level
$24.70
Relative Strength Index (RSI14)
Sell
Level
39.66
ADX Line
Sell
Level
15.86
Williams %R
Buy
Level
-93.7662
50-day SMA
Sell
Level
$23.70
MACD (12, 26)
Sell
Level
-0.07
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
44.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4324)
Buy
CA Score
(Annual)
Level (0.1808)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.583)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Stock Forecast FAQ
In the current month, XNCR has received 7 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XNCR average analyst price target in the past 3 months is $32.50.
-
Where Will Xencor Stock Be In 1 Year?
According to analysts, the consensus estimate is that Xencor share price will rise to $32.50 per share over the next 12 months.
-
What Do Analysts Say About Xencor?
Analysts are divided on their view about Xencor share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xencor is a Sell and believe this share price will drop from its current level to $22.00.
-
What Is Xencor's Price Target?
The price target for Xencor over the next 1-year time period is forecast to be $32.50 according to 7 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is XNCR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Xencor is a Buy. 7 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of XNCR?
You can purchase shares of Xencor via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xencor shares.
-
What Is The Xencor Share Price Today?
Xencor was last trading at $23.92 per share. This represents the most recent stock quote for Xencor. Yesterday, Xencor closed at $22.98 per share.
-
How To Buy Xencor Stock Online?
In order to purchase Xencor stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Adobe Stock Dropping?
Why is Adobe stock dropping? A combination of underwhelming fiscal…
Why Is 3M Stock Going Up?
After a decade-long slump in new product introductions, the leading…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 41x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
77
FTAI alert for Jan 2
FTAI Aviation [FTAI] is up 0.19% over the past day.
Buy
56
QMCO alert for Jan 2
Quantum [QMCO] is down 4.86% over the past day.
Buy
60
ARQQ alert for Jan 2
Arqit Quantum [ARQQ] is down 5.74% over the past day.
